Executive Briefing | October 30, 2018

Wait… MACRA Impacts Med Supp?

By

A tectonic shift is underway in the Medicare Supplemental (Med Supp) market and it’s coming from a source rarely discussed—the Medicare Access and CHIP Reauthorization Act (MACRA). Beginning in 2020, insurers will no longer be able to sell the most…

Read More

Executive Briefing | July 20, 2017

You Can’t Spell MACRA Without MA

By

Is your organization MACRA ready? If so, you have probably invested significantly in infrastructure, innovative policies and procedures focused on care management, and consumer engagement strategies. MACRA is here to stay, but have you considered the broader Senior Market opportunity?…

Read More

Executive Briefing | December 6, 2016

Does MACRA Still Matter?

By

By now you are undoubtedly familiar with the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The resulting Quality Payment Program (QPP) and its two participation pathways – Advanced Alternative Payment Models (APMs) and Merit-based Incentive Payment System (MIPS)…

Read More

hfm Magazine | November 15, 2016

Translating Risk into Revenue

By

Health plan revenue is increasingly tied to the concept of risk adjustment. In practice, risk adjustment aligns payments received by health plans with the risk of the populations they manage. Although each market has its own unique version of risk…

Read More

Whitepaper | August 16, 2016

MACRAnomics: Patient-Level Economics and Strategic Implications for Providers

By

MACRA offers provider organizations strategic opportunities to think differently about their business models and pursue sustainable growth and margin levels. With increased accountability stemming from MACRA and related APMs, patient economics has come at the forefront of long-term strategy development.…

Read More